Must you send the product back, or is a contact request sufficient
In controlled trials, RDN-delivered MNT modestly but meaningfully improves dietary quality, body weight, waist circumference, glycemic control, blood pressure, and blood cholesterol levels [[207], [208], [209], [210]]
Market Statistics Key Takeaways North America led with a 75.46% revenue share in 2025
In short: The medication and clinical experience are solid, and the variety of formats is a genuine differentiator
June 4, 2024 | Global Equity It seems like everyone is talking about Ozempic, but this popular weight loss drug is only one of many glucagon-like peptide-1 (GLP-1) medications establishing themselves as the cornerstone in the management of obesity